Physician profile
Aaron Blackham
NPI 1790965358
$1,890.48
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $103 · 2021: $14.00 · 2022: $81.25 · 2023: $380 · 2024: $1,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $777 · Travel and Lodging: $605 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $776.72 |
| Travel and Lodging | $604.86 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,010.48 | 2024 | |
| Kerecis Limited | $338.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Abbvie INC. | $101.17 | 2020-2023 | Creon |
| Merck Sharp & Dohme LLC | $80.91 | 2019-2021 | |
| Tactile Systems Technology INC | $71.61 | 2019-2022 | |
| Steris Corporation | $52.53 | 2020 | |
| Incyte Corporation | $30.44 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $26.24 | 2019 | |
| Seagen INC. | $22.12 | 2019 | |
| Celgene Corporation | $20.68 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.43 | 2019 | |
| Genzyme Corporation | $16.48 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.92 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.75 | 2019 | |
| Janssen Biotech, INC. | $15.06 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.53 | 2019 | |
| Amgen INC. | $13.72 | 2019 | |
| Daiichi Sankyo INC. | $13.66 | 2019 | |
| Astellas Pharma US INC | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Blackham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.